Status
Conditions
Study type
Funder types
Identifiers
About
Psychotic symptoms (hallucinations and delusions) are present in several psychiatric and neurological disorders as well as in the general population. Effective treatment strategies for these symptoms in all patients are lacking and treatment-response can presently not be predicted. To date, the exact pathophysiological mechanism of these symptoms remains unknown. By investigating (subtypes) of hallucinations and delusions in all populations, a common pathway may be found, leading to more effective treatment options. Alternatively, different subtypes may be associated with different pathophysiological mechanisms.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
700 participants in 11 patient groups
Loading...
Central trial contact
Mascha M.J. Linszen, MD; Sophie M. Heringa, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal